Telix Pharmaceuticals (TLX) Free Cash Flow (2011 - 2025)
Telix Pharmaceuticals (TLX) free cash flow from Jun 30, 2011 to Dec 31, 2025. The TTM Telix Pharmaceuticals (TLX) free cash flow is -$34M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Telix Pharmaceuticals (TLX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +1.21% |
| 10 Years TTM | +33.75% |
| All Time TTM | +63.03% |
Annual Free Cash Flow change of Telix Pharmaceuticals (TLX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$55M | -410.99% |
| 2024 | $18M | +83.79% |
| 2023 | $9.66M | -120.02% |
| 2022 | -$48M | +9.66% |
| 2021 | -$44M | -3445.47% |
| 2020 | $1.32M | -107.90% |
| 2019 | -$17M | +12.74% |
| 2018 | -$15M | +165.69% |
| 2017 | -$5.56M | +98.03% |
| 2016 | -$2.81M | +2.67% |
| 2015 | -$2.73M | +69.08% |
| 2014 | -$1.62M | +28.61% |
| 2013 | -$1.26M | -808.88% |
| 2012 | $177K | -129.88% |
| 2011 | -$593K | N/A |
Comparison Telix Pharmaceuticals (TLX) five years free cash flow CAGR with competitors
Telix Pharmaceuticals (TLX) five years free cash flow CAGR is 43.67%.